| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/20/2005 | CN1211122C Heat-resisting lyophilized protectant for swine fever lapinized hyoptoxicity calf testicular cell vaccine and preparing process |
| 07/20/2005 | CN1211121C Quadrivalent combination vaccine including diphtheria toxoid, tetanus toxoid, whole cell pertussis and hepatitis B surface antigen, and prepn. method thereof |
| 07/20/2005 | CN1211080C Method for preparing microcapsule |
| 07/19/2005 | US6919442 Nucleic acids comprising a post-transcriptional regulatory element (PRE) and their uses |
| 07/19/2005 | US6919438 Comprises viral expression vector coding envelope protein domains for use as gene therapeutic tool in the treatment of autoimmune diseases |
| 07/19/2005 | US6919436 Isolation of proteins |
| 07/19/2005 | US6919435 Comprises cancer marker glycoprotein for diagnosis of stomach, colon and breast cancers |
| 07/19/2005 | US6919319 Immuno-modulating effects of chemokines in DNA vaccination |
| 07/19/2005 | US6919318 Enhancing immune responses to genetic immunization by using a chemokine |
| 07/19/2005 | US6919203 Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus |
| 07/19/2005 | US6919187 Comprises polypeptides for use in serodiagnosis and treatment of chlamydial sexually transmitted disease; vaccines |
| 07/19/2005 | US6919086 Graminae pollen allergen mutants for specific immunotherapy, and production and use of the same |
| 07/19/2005 | US6919085 E2 subunit vaccine comprising recombinant pestivirus E2 protein |
| 07/19/2005 | US6919084 Antigen strain in vehicle; inducting immunology response |
| 07/19/2005 | US6919083 Fish vaccine |
| 07/19/2005 | US6919081 Lak activity potentiator orginating in shitake mushroom hyphae extract and lak activity potentiating preparations containing the same |
| 07/19/2005 | US6919080 Polypeptide for use in the treatment of respiratory disorders in poultry |
| 07/19/2005 | US6919079 FcεPE chimeric protein for targeted treatment of allergy responses, a method for its production and pharmaceutical compositions containing the same |
| 07/19/2005 | US6919075 Bacteriophage displaying aβ epitopes and method of use |
| 07/19/2005 | US6919070 Stomatic composition |
| 07/19/2005 | CA1341486C Modified protein a |
| 07/14/2005 | WO2005063991A2 Live genetically attenuated malaria vaccine |
| 07/14/2005 | WO2005063973A1 Methods and kits for predicting an infectious disease state |
| 07/14/2005 | WO2005063815A2 Fcϝ receptor-binding polypeptide variants and methods related thereto |
| 07/14/2005 | WO2005063805A1 Antibodies against the amino terminus region of circumsporozoite protein prevent the onset of malaria infection |
| 07/14/2005 | WO2005063804A1 Compounds useful in the diagnosis and treatment of malaria |
| 07/14/2005 | WO2005063802A2 Haemophilus influenzae type iv pili |
| 07/14/2005 | WO2005063801A2 Method for decreasing the contact between hepta-repeat region s of the corona-virus spike proteins and use thereof |
| 07/14/2005 | WO2005063798A1 Identification of two linear epitopes on ebola or marburg virus glycoproteins critical for infection |
| 07/14/2005 | WO2005063292A2 Heh4 molecules and uses thereof |
| 07/14/2005 | WO2005063289A1 Cd40 antibody formulation and methods |
| 07/14/2005 | WO2005063288A1 Synergistic liposomal adjuvants |
| 07/14/2005 | WO2005063287A1 Proteoliposomes and derivatives thereof as cytotoxic response-inducing adjuvants and resulting formulations |
| 07/14/2005 | WO2005063286A1 Antibodies for oncogenic strains of hpv and methods of their use |
| 07/14/2005 | WO2005063284A1 Combination vaccine for poultry |
| 07/14/2005 | WO2005063283A1 Vaccine comprising recombinant clpp protein of streptococcus pneumoniae |
| 07/14/2005 | WO2005063280A1 Allogeneic tumor therapeutic agent |
| 07/14/2005 | WO2005063264A1 Immunopotentiator and method of enhancing immunological activity with the same |
| 07/14/2005 | WO2005063220A1 Modulation of 5-ht2 receptors as a treatment for cardiovascular diseases |
| 07/14/2005 | WO2005062977A2 Prostate cancer specific internalizing human antibodies |
| 07/14/2005 | WO2005062972A2 Treatment of cancer with novel anti-il 13 monoclonal antibodies |
| 07/14/2005 | WO2005062967A2 Novel anti-il 13 antibodies and uses thereof |
| 07/14/2005 | WO2005062916A2 Methods for generating multimeric molecules |
| 07/14/2005 | WO2005062893A2 Anti-cd52 antibody treatment for diabetes |
| 07/14/2005 | WO2005062871A2 Tat linear epitope peptides and conjugates thereof for use in therapeutic compositions and assays |
| 07/14/2005 | WO2005062820A2 Multi plasmid system for the production of influenza virus |
| 07/14/2005 | WO2005062709A2 Integrated viral complexes, methods of production thereof, vaccines containing same and methods of use thereof |
| 07/14/2005 | WO2005053505A3 Use of gene ncsag4 for the diagnosis and prevention of neosporosis and as a marker for analysis of the pathogenesis |
| 07/14/2005 | WO2005044188A3 Compositions and methods to modulate an immune response to an immunogenic therapeutic agent |
| 07/14/2005 | WO2005035779A3 Method |
| 07/14/2005 | WO2005027829A3 Method for vaccination of poultry by bacteriophage lysate |
| 07/14/2005 | WO2005002515A3 Delivery of therapeutic compounds to the brain and other tissues |
| 07/14/2005 | WO2005000871A3 Peptides antagonistic to an anti-angiogenic antibody and uses therefor |
| 07/14/2005 | WO2004113374A3 Chlamydia pneumoniae antigens |
| 07/14/2005 | WO2004105729A3 Transdermal vaccine delivery device having coated microprotrusions |
| 07/14/2005 | WO2004101747A3 Identification and use of gpr54 and its ligands for reproductive disorders and contraception |
| 07/14/2005 | WO2004098535A3 Modified antibodies to prostate-specific membrane antigen and uses thereof |
| 07/14/2005 | WO2004091375A3 Epha2 and non-neoplastic hyperproliferative cell disorders |
| 07/14/2005 | WO2004031211A8 Hla binding peptides and their uses |
| 07/14/2005 | WO2004017923A3 Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ix |
| 07/14/2005 | WO2003082212A3 Method for treating cancer in humans |
| 07/14/2005 | WO2002072793A3 Expression of properly folded and soluble extracellular domain of a gonadotropin receptor |
| 07/14/2005 | US20050155113 Expression vector comprising nucleotide sequences coding norwalk virus capsid protein for use in generating vaccine for prevention and treatment of gastrointestinal disorders |
| 07/14/2005 | US20050155089 Transport protein for use in identifying modulators for prevention and treatment of inflammation, cardiovascular, neurological, reproductive and developmental disorders |
| 07/14/2005 | US20050154165 Ph-sensitive polymer |
| 07/14/2005 | US20050153923 Receptor protein kinases (EphA2/EphA4); gene expression inhibition; rna interference; for treatment, management, or prevention of hyperproliferative cell disease/cancer |
| 07/14/2005 | US20050153917 Gene overexpression/underexpression; antibodies; drug screening; kits |
| 07/14/2005 | US20050153910 Antibody and inhibitor and transformation method and transformation kit using the same |
| 07/14/2005 | US20050153888 oligopeptides capable of stimulating the proliferation or/and the outgrowth from cells presenting the neural cell adhesion molecule (NCAM), used for treatment of normal, degenerated and damaged NCAM presenting cells |
| 07/14/2005 | US20050153887 Compositions for inducing cell growth and differentiation and methods of using same |
| 07/14/2005 | US20050153878 Fgfr agonists |
| 07/14/2005 | US20050153871 Administering N-hydroxy-N-(4-butyl-2-methylphenyl)-formamidine (HET0016) to increase or prevent a decrease in cerebral blood flow |
| 07/14/2005 | US20050153439 Ecstasy-class derivatives, immunogens, and antibodies and their use in detecting ecstasy-class drugs |
| 07/14/2005 | US20050153376 Superantigens |
| 07/14/2005 | US20050153374 Peptides and polypeptides derived from the submaxillary gland of the rat, corresponding polyclonal and monoclonal antibodies, corresponding hybridomas and uses of these products for diagnosis, for detection or therapeutic purposes |
| 07/14/2005 | US20050153367 Method of detecting immune response |
| 07/14/2005 | US20050153332 Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 07/14/2005 | US20050153279 Viral variants with altered susceptibility to nucleoside analogs and uses thereof |
| 07/14/2005 | US20050153057 Lipopolysaccharide for influenza vaccines and respiratory system disorders |
| 07/14/2005 | US20050153004 plant extracts used as adjuvants for DNA vaccines, to improve immune responses in mammals |
| 07/14/2005 | US20050152980 Pharmeutical microparticles |
| 07/14/2005 | US20050152963 Liposome compositions |
| 07/14/2005 | US20050152930 Parakeratosis inhibitor, pore-shrinking agent and skin preparation for external use |
| 07/14/2005 | US20050152927 Allergenic proteins and peptides from Japanese cedar pollen |
| 07/14/2005 | US20050152926 For immunization and/or diagnosis; eg pneumonia, cardiovascular diseases, atherosclerosis, bronchitis |
| 07/14/2005 | US20050152922 Use of polysaccharides containing the tetrasaccharide repeat unit to induce serum antibodies having bactericidal activity against hemolytic-uremic syndrome (HUS) causing E. coli, in particular E. coli O157 |
| 07/14/2005 | US20050152921 Modified CpG oligodeoxynucleotide with improved immunoregulatory function |
| 07/14/2005 | US20050152920 Nucleic acid sequence comprising the rna packaging signal of a group 1 coronavirus and the applications thereof |
| 07/14/2005 | US20050152919 Measles virus antigens with a Proteosome-based adjuvant; treating or preventing a measles virus infection |
| 07/14/2005 | US20050152917 Fusion protein for use in the treatment of viral diseases |
| 07/14/2005 | US20050152915 Exposure of tumor cells obtained ex vivo or pathological cells of a non-tumorous nature or of a biological fluid of a mammal containing viruses or bacteria to radiation of the optical range, the administering them into the lymphatic system ; enhances the efficacy and usability of immunotherapy |
| 07/14/2005 | US20050152914 Diagnosis, therapy, prevention of autoimmune diseases, antiallergies; graft versus host disease, anticancer agents; stimulant of immune system |
| 07/14/2005 | US20050152913 Process for preapring maytansinol |
| 07/14/2005 | US20050152911 Norovirus monoclonal antibodies and peptides |
| 07/14/2005 | US20050152909 Prostate stem cell antigen (PSCA) tumor antigen for use in diagnosis, prevention and treatment of prostate cancers |
| 07/14/2005 | US20050152908 Expressed in blood and useful in diagnosing liver cancer as well as monitoring therapeutic efficacy; polynucleotides; eg amyloid beta (A4) precursor-like protein 2 (APLP2); BCL2-related protein A1 (BCL2A1) |
| 07/14/2005 | US20050152907 Used to diagnose and treat various diseases, including human cancers associated with expression and/or over-expression of KID3 |
| 07/14/2005 | US20050152902 administering antibodies to gamma interferon and CD20 antigens |
| 07/14/2005 | US20050152899 EphA2 agonistic monoclonal antibodies and methods of use thereof |
| 07/14/2005 | US20050152898 Provides for modified forms of anti-CD52 antibodies with reduced numbers of potential T-cell epitopes that are expected to display decreased immunogenicity, for therapy of autoimmune conditions |